- Home
- » Tags
- » Coumermycin A1
Top View
- Designing Type II Topoisomerase Inhibitors: a Molecular Modeling Approach
- Aug. 17, 1965 3,201,386
- DNA Topoisomerases I from Pseudomonas Aeruginosa And
- (12) Patent Application Publication (10) Pub. No.: US 2003/0059471 A1 Compton Et Al
- Calcio Gaudino, E.; Tagliapietra, S.; Martina, K.; Palmisano, G.; Cravotto, G
- Current Evidence for Corynebacterium on the Ocular Surface
- Antagonism Between Novobiocin and Coumermycin A1 in Bacillus Subtilis
- DNA Gyrase on the Bacterial Chromosome: Possibility of Two Levels of Action (Oxolinic Acid/DNA Synthesis/Reca Mutant) KARL DRLICA, ELIZABETH C
- (12) Patent Application Publication (10) Pub. No.: US 2010/0234348 A1 Cottarel Et Al
- Antibacterial Agents: 1,4-Disubstituted 1,2,3-Triazole Analogs of the Oxazolidinone a Dissertation Presented to the Faculty Of
- Opposing Effects of Target Overexpression Reveal Drug Mechanisms
- Nalidixic Acid Resistance: a Second Genetic Character Involved in DNA
- Expanding the Potential of Mutasynthetic Approaches for Pseudomonic Acids
- Antimicrobial Resistance in the 21St Century, Emerging Infectious Diseases of the 21St Century, 756 Index
- Arabidopsis Thaliana DNA Gyrase Is Targeted to Chloroplasts and Mitochondria
- The Role of Seaweed Antimicrobials in Selection for Antibiotic Resistance
- Anti-Plasmid and Plasmid Curing', FEMS Microbiology Reviews, Vol